Estimated effect of COVID‐19 lockdown on melanoma thickness and prognosis: a rate of growth model

The coronavirus COVID-19 pandemic, which emerged in Wuhan, China several months ago,1 has led to large-scale lockdown in many countries around the world, including Spain. Uncertainty about the duration of these measures led us to consider the potential impact of diagnostic delays due to the paralyzation of certain health procedures and services on the prognosis of patients with melanoma.

[1]  L. French,et al.  Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  A. Offidani,et al.  Global coronavirus pandemic (2019‐nCOV): implication for an Italian medium size dermatological clinic of a II level hospital , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  L. Gostin,et al.  The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.

[4]  Jeffrey E Gershenwald,et al.  Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[5]  E. Blackstone,et al.  Cancer of the esophagus and esophagogastric junction—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[6]  P. Serra-Arbeloa,et al.  Estudio descriptivo de costes en melanoma cutáneo de diferentes estadios , 2017 .

[7]  F. Guillén-Grima,et al.  Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis. , 2017, Actas dermo-sifiliograficas.

[8]  I. Pastushenko,et al.  Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis. , 2016, Actas dermo-sifiliograficas.

[9]  A. Parodi,et al.  Dermatological consultations in an observation unit of an emergency department in Italy , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  C. Mclean,et al.  An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed. , 2014, Journal of the American Academy of Dermatology.

[11]  E. Nagore,et al.  Registro nacional de melanoma cutáneo. Características del tumor en el momento del diagnóstico: 15 años de experiencia , 2013 .

[12]  P. Jaen,et al.  Dermatologic emergencies: descriptive analysis of 861 patients in a tertiary care teaching hospital. , 2013, Actas dermo-sifiliograficas.

[13]  E. Nagore,et al.  Prediction of sentinel lymph node positivity by growth rate of cutaneous melanoma. , 2012, Archives of dermatology.

[14]  S. Swadron,et al.  Cutaneous Conditions Leading to Dermatology Consultations in the Emergency Department , 2011, The western journal of emergency medicine.

[15]  R. Botella-Estrada,et al.  Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  E. Herrera‐Ceballos,et al.  Growth rate as a prognostic factor in localized invasive cutaneous melanoma , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  A. Philalithis,et al.  Primary care and pattern of skin diseases in a mediterranean island , 2006, BMC family practice.

[18]  B. Kumar,et al.  Evaluation of emergency dermatological consultations in a tertiary care centre in North India , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  J. Grob,et al.  The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: A prospective study , 2002, International journal of cancer.